Skip to main content
logo
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
56.67
+0.34 (0.60%)
At close: Mar 23, 2026, 4:00 PM EDT
56.79
+0.12 (0.21%)
Pre-market: Mar 24, 2026, 5:18 AM EDT

Arrowhead Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Cap
7,9364,6802,4092,8833,5026,513
Market Cap Growth
256.15%94.27%-16.45%-17.66%-46.23%47.75%
Enterprise Value
7,7194,6632,6092,8693,2246,169
Last Close Price
56.6734.4919.3726.8733.0562.43
PE Ratio
38.42-3449.00-3.87-13.99-19.79-45.90
PS Ratio
7.275.64678.4511.9814.4047.10
PB Ratio
13.7010.0413.1910.638.7915.93
P/TBV Ratio
13.699.9012.7010.578.7415.84
P/FCF Ratio
24.6429.83-3.99-8.72-18.5444.08
P/OCF Ratio
23.3926.07-5.21-18.74-25.7338.02
EV/Sales Ratio
7.085.62734.6211.9213.2644.61
EV/EBITDA Ratio
23.7038.13-4.48-14.90-19.18-43.82
EV/EBIT Ratio
25.6847.41-4.34-13.99-18.06-41.39
EV/FCF Ratio
23.9729.72-4.32-8.68-17.0741.75
Debt / Equity Ratio
1.211.444.431.300.190.06
Debt / EBITDA Ratio
2.126.00-1.46-1.99-0.48-0.18
Debt / FCF Ratio
2.144.68-1.41-1.16-0.430.17
Net Debt / Equity Ratio
-0.17-0.101.08-0.07-0.74-0.84
Net Debt / EBITDA Ratio
-0.30-0.39-0.340.111.752.43
Net Debt / FCF Ratio
-0.31-0.30-0.330.061.56-2.32
Asset Turnover
0.830.660.000.330.350.22
Quick Ratio
2.894.036.343.832.722.58
Current Ratio
3.384.866.743.952.922.62
Return on Equity (ROE)
75.50%8.67%-254.98%-59.33%-42.67%-32.36%
Return on Assets (ROA)
21.04%4.55%-62.81%-28.51%-26.02%-24.18%
Return on Invested Capital (ROIC)
54.20%13.40%-182.08%-79.62%-64.84%-60.11%
Return on Capital Employed (ROCE)
27.62%8.83%-70.85%-33.80%-31.97%-28.51%
Earnings Yield
2.55%-0.03%-25.81%-7.15%-5.05%-2.18%
FCF Yield
4.06%3.35%-25.08%-11.47%-5.39%2.27%
Buyback Yield / Dilution
-2.07%-5.78%-17.92%-0.11%-0.15%-0.17%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q